REYON Pharmaceutical Co., Ltd. (KRX:102460)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,940
+150 (1.39%)
At close: Nov 4, 2025

REYON Pharmaceutical Market Cap

REYON Pharmaceutical has a market cap or net worth of 196.62 billion as of November 5, 2025. Its market cap has decreased by -21.75% in one year.

Market Cap
196.62B
Enterprise Value
396.83B
Revenue
150.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
10,940.00

Market Cap Chart

Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 196.62B, an increase of 19.48%. That is a compound annual growth rate of 1.16%.

History

DateMarket Cap% Change
Nov 5, 2025196.62B-16.51%
Dec 30, 2024235.50B-22.37%
Dec 28, 2023303.36B-21.07%
Dec 29, 2022384.35B-39.10%
Dec 30, 2021631.11B61.64%
Dec 30, 2020390.43B47.64%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Samsung Biologics86.90T
Celltrion38.84T
ALTEOGEN29.36T
SK Biopharmaceuticals9.42T
Yuhan9.01T
HLB Co., Ltd.7.03T
Peptron6.33T
ABL Bio6.13T
Market Cap Rankings